RedHill Biopharma Ltd.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $81.4M | $13.9M | $29.3M |
| FY2021 | $83.6M | $8.9M | $29.5M |
| FY2022 | — | $-48.4M | $20.0M |
| FY2023 | — | $2.1M | $5.6M |
| FY2024 | — | $-4.7M | $4.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | $81.4M | $13.9M | $29.3M |
| FY2021 | $83.6M | $8.9M | $29.5M |
| FY2022 | — | $-48.4M | $20.0M |
| FY2023 | — | $2.1M | $5.6M |
| FY2024 | — | $-4.7M | $4.6M |